CN108323600A - A kind of health care ferment tea solid electuary and its production method - Google Patents
A kind of health care ferment tea solid electuary and its production method Download PDFInfo
- Publication number
- CN108323600A CN108323600A CN201810157765.4A CN201810157765A CN108323600A CN 108323600 A CN108323600 A CN 108323600A CN 201810157765 A CN201810157765 A CN 201810157765A CN 108323600 A CN108323600 A CN 108323600A
- Authority
- CN
- China
- Prior art keywords
- powder
- ferment
- health care
- parts
- tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 41
- 239000007787 solid Substances 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 241001122767 Theaceae Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 105
- 244000269722 Thea sinensis Species 0.000 claims abstract description 62
- 235000013616 tea Nutrition 0.000 claims abstract description 43
- 238000000855 fermentation Methods 0.000 claims abstract description 34
- 230000004151 fermentation Effects 0.000 claims abstract description 34
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 20
- 235000020279 black tea Nutrition 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 17
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 13
- 235000006533 astragalus Nutrition 0.000 claims abstract description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 13
- 229940029339 inulin Drugs 0.000 claims abstract description 13
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 12
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 12
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000013312 flour Nutrition 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 12
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 11
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 11
- 229940010454 licorice Drugs 0.000 claims abstract description 11
- 241000894006 Bacteria Species 0.000 claims abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 10
- 235000021419 vinegar Nutrition 0.000 claims abstract description 10
- 239000000052 vinegar Substances 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims abstract description 9
- 235000009508 confectionery Nutrition 0.000 claims abstract description 7
- 239000006041 probiotic Substances 0.000 claims abstract description 7
- 235000018291 probiotics Nutrition 0.000 claims abstract description 7
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 6
- 230000003213 activating effect Effects 0.000 claims abstract description 6
- 238000004090 dissolution Methods 0.000 claims abstract description 6
- 235000012907 honey Nutrition 0.000 claims abstract description 5
- 239000005030 aluminium foil Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 3
- 240000002045 Guettarda speciosa Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 18
- 238000004321 preservation Methods 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 239000012982 microporous membrane Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 238000009434 installation Methods 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 10
- 239000004615 ingredient Substances 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 4
- 239000011435 rock Substances 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract 2
- 238000012856 packing Methods 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 9
- 244000061520 Angelica archangelica Species 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000011201 Ginkgo Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- -1 energy used Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000011707 mineral Chemical class 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-JGVFFNPUSA-N (1r,5s)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-one Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2=O IECBDTGWSQNQID-JGVFFNPUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- IECBDTGWSQNQID-UHFFFAOYSA-N Chrysanthenon Natural products CC1=CCC2C(C)(C)C1C2=O IECBDTGWSQNQID-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-SFYZADRCSA-N Chrysanthenone Natural products CC1=CC[C@H]2C(C)(C)[C@@H]1C2=O IECBDTGWSQNQID-SFYZADRCSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of health care ferment tea solid electuary and its production method, using ginkgo biloba p.e, black tea powder, honeysuckle powder, astragalus membranaceus powder, angelica powder, inulin, longan powder, wolfberry fruit powder, malt flour, licorice powder as health care's ferment solid granules that primary raw material, auxiliary material are the making such as candy sugar powder.Above-mentioned raw materials are first added into corresponding purifying water dissolution, again Icing Sugar heating on the rocks, dissolving sterilizing, it is separately added into saccharomycete activating solution, acetic acid bacteria, probiotics again and carries out fermentation generation ferment feed liquid three times, the allotment such as honey, apple vinegar, filtering are used again, is freeze-dried into powder, and functional health solid granules are made in last aluminium foil packing.Manufactured health care ferment tea is on the basis of containing amino acid, also contain a large amount of health nutrient ingredients, micro constitutent and tea nutritional ingredient, enhance people's constitution, improves immunity, with health-care efficacies such as hypertension and hyperlipemia, cleaning enteron aisle, prevention and cure of cardiovascular disease, drinks dosage accurately and drink conveniently.
Description
Technical field
The present invention relates to a kind of health care ferment tea solid electuary and its production methods, belong to beverage production field.
Background technology
Ferment is a kind of substance with special bioactivity being made of amino acid, it is present in the animals and plants of all work
In vivo, it is to maintain body normal function, digests food, a kind of necessary material of the vital movements such as repair tissue.Ferment is to life
Importance it is self-evident, ferment, that is, administer the substance of all vital movements.Chemical change in organism, nearly all
It to be carried out under the catalytic action of ferment.
The type of ferment is various, some ferment can be breaks down proteins at more simple compound, and other ferment then can
These compounds are resolved into more simple substance again, until breaks down into amino acids, most Hou becomes water and carbon dioxide.Food
The function that the decomposition of object has to rely on hundreds of different ferment can just be reached, and the protein of meat etc., fat also must have more
The catalytic action of kind ferment, could complete digestion and metabolic process.
Ferment can be food digest completely, clean, have the possibility liquid matter for adjusting microorganism, natural equilibrium original
Abundant micro constitutent characteristic.Therefore, ferment is recognized the health-care effect of human body by people in recent years, and ferment is difference
The combination of the amino acid of type constitutes various protein, batch ferment drink occurs on existing market, such as various vegetables and fruits,
The ferment drink such as plant enzyme, product is more single, and people need more cardiovascular to human body or promote the guarantors such as immune function
Health-care function ferment, and the transport of existing liquid ferment drink is drunk extremely inconvenient with personal carry, and does not drink dosage accurately,
Far can not meet the needs of people are to health nutrient and life.
Invention content
The problem to be solved in the present invention is vegetables and fruits ferment single varieties, health nutrient ingredient not abundant and liquid ferment drink
It is inconvenient to carry, the inaccurate problem of dosage is drunk, a kind of health care ferment tea solid electuary and its production method are provided, carried with ginkgo leaf
It is that raw material is sent out through special process to take 10 kinds of traditional Chinese medicine powders such as object, black tea powder, honeysuckle powder, astragalus membranaceus powder, angelica powder, inulin and Plant Powder
Health care ferment tea solid electuary is made in ferment, and ferment tea also contains a large amount of health nutrient ingredients, micro on the basis of containing amino acid
Ingredient and tea nutritional ingredient enhance people's constitution, improve immunity, have hypertension and hyperlipemia, cleaning enteron aisle, prevention and cure of cardiovascular disease
Equal health-care efficacies are drunk dosage accurately and are drunk conveniently.
In order to solve the above technical problems, the technical solution adopted by the present invention is:A kind of health care ferment tea solid electuary, it is special
Sign is:Including following raw material:8~10 parts of ginkgo biloba p.e, 10~12 parts of black tea powder, 5~8 parts of honeysuckle powder,
4~6 parts of astragalus membranaceus powder, 5~7 parts of angelica powder, 10~12 parts of inulin, 4~6 parts of longan powder, 5~7 parts of wolfberry fruit powder, malt flour 10~
12% part, 4~6 parts of licorice powder are equipped with 20~30% candy sugar powder of raw material total amount, fermented to be processed into the punching of health care ferment tea solid
Agent.
A kind of production method of health care ferment tea solid electuary, procedure of processing are as follows:
1)Fermentation tank disinfection and sterilization, by ginkgo biloba p.e, black tea powder, honeysuckle powder, astragalus membranaceus powder, angelica powder, inulin, longan
10 kinds of powder, wolfberry fruit powder, malt flour, licorice powder raw materials are placed in fermentation tank according to the ratio, and 3~3.5 times of purified waters of raw material total amount is added to add
Thermal agitation is dissolved;Again plus 20~30% candy sugar powders of raw material total amount, mixed dissolution sterilize 25~30 minutes;
2)When temperature is down to 30~35 DEG C, be added 6~8% saccharomycete activating solution carry out one time fermentation, stir evenly it is closed,
30~35 DEG C of heat preservation stops fermentation when ethanol content reaches 5.5~6.5%;
3)Add 6~8% acetic acid bacterias carry out secondary fermentation, stir evenly it is closed, keep the temperature 30~35 DEG C, wait for that ethanol content is less than
When 1%, stop fermentation;
4)8~10% probiotics are added to be fermented three times, stir evenly it is closed, keep the temperature 35~38 DEG C, ferment tea material is made
Liquid;
In the ferment feed liquid plus honey, apple vinegar flavor adjustment, with filtering with microporous membrane, then spraying is freeze-dried into ferment tea
Powder, finally above racking machine dresses up disposable health ferment tea solid electuary with aluminium foil bag.
The invention has the advantages and positive effects that:
1, health care ferment tea solid electuary of the present invention, health care ferment tea have sustain life necessary to clean energy glucose and
" amino acids, lactic acid, acetic acid etc. after vitamin, minerals class, protein are decomposed have necessary to fructose, metabolism
Machine acids and abundant micro constitutent, due to being to make full use of the distinctive nutritional ingredient of Chinese herbal medicine powder and micro constitutent and Cha Ying
A point progress zymotechnique is formed, there is the chrysanthemum glucoside etc. of chlorogenic acid, the flavonoids of abundant honeysuckle liquid, ginkgo biloba p.e and chrysanthemum
Effective ingredient has acid resistance(Lactic acid bacteria class), osmotic-pressure-tolerant microorganism(Special useful yeast class), it is clean and safe
The alternative fermentation of liquid matter fermentative microorganism, the present invention are filled in batches using three Yeasts, acetic acid bacteria, probiotics leaven
Distribution ferment helps ferment, generates organic acids and the abundant micro constitutents such as amino acids, lactic acid, acetic acid, is not consumed not only when drinking
The nutritional ingredients such as energy used, vitamin, minerals when change are entirely free of " fat, protein " class of animality, are rich in energy
Source and " physiological activator " to boost metabolism, natural energy guides physical qualification into kilter, and can remove makes body give birth to
The active acid element of rust, acts on, by body absorption, improves immunity in the intestine, has clearing heat and detoxicating, thin throat effect, together
When have decompression, hypoglycemic, lipid-loweringing, reduce cholesterol, softening blood vessel effect, cerebral hemorrhage and cerebral infarction can be prevented and treated, come of age
Angina pectoris improves immunity, takes care of health effect to the distinctive dietotherapy of human body disease preventing and treating.
2, health care ferment tea solid electuary of the present invention, with ginkgo biloba p.e, black tea powder, honeysuckle powder, astragalus membranaceus powder, Radix Angelicae Sinensis
Based on the Chinese herbal medicines powder such as powder, inulin, longan powder, wolfberry fruit powder, malt flour, licorice powder, prepared through special process processing and fermentation
At health care ferment tea liquid;Ginkgo biloba p.e includes flavones 24%, terpene lactones 6%, procyanidine class 7.0%, catechin
2.0%, Folium Ginkgo is used for chest impediment and cardialgia, apoplexy, hemiplegia caused by obstruction of collaterals by blood stasis, and the strong language of tongue is stuttering;The coronary heart disease stable type heart
The diseases such as angina, cerebral infarction, Folium Ginkgo have expansion of cerebral vascular, increase cerebral blood flow (CBF), ginkgo biloba p.e active ingredient is added
Enter in beverage, expand the integration of drinking and medicinal herbs of Chinese medicine, diet-therapy health-preserving theory extensive use, make people it is daily drink functional beverage and
Non-drug therapy prevents cardiovascular and cerebrovascular disease, prevents cerebral arteriovenous malformation and treatment senile dementia etc. from playing a role.
3, health care ferment tea solid electuary of the present invention, honeysuckle powder contain volatility honeysuckle aromatic oil, inositol, saponin(e,
The compounds such as chlorogenic acid, flavonoids, cinnamic acid, nerol, jasmine arrive aldehyde etc., chlorogenic acid be honeysuckle main pharmacodynamics activity at
Point, also compounds such as flavonoids, the active ingredients such as other volatility lonicera oils also values such as great medicinal, beauty, Chinese medicine
There is the effect of clearing heat and detoxicating, wind-heat dissipating, hepatic cholagogic, carbuncle swells to treat sore, larynx for honeysuckle, sweet in flavor, cold in nature, fragrant odour
Numbness, anemopyretic cold etc., which all has, to be had a better effect.
4, health care ferment tea solid electuary of the present invention, black tea powder category full fermentation teas, the flavonoid being rich in black tea
Object can eliminate free radical, have scavenging activity, reduce the incidence of myocardial infarction.Antioxidant in black tea powder can be thorough
The propagation path of chemical substance in cancer cell is destroyed, it is more in the black tea such as Polyphenols, carbohydrate, amino acid, pectin in black tea powder
Phenolic compound has the effect of anti-inflammatory, and the caffeine in black tea powder carrys out excitor nerve maincenter by stimulation cerebral cortex, facilitates
Refresh oneself, under the caffeine and aromatic substance synergy in black tea powder, increases the blood flow of kidney, the anti-inflammatory of black tea powder energy is protected
Stomach lining is protected, also has certain effect to treatment ulcer.
5, health care ferment tea solid electuary of the present invention, astragalus membranaceus powder slightly warm in nature sweet in flavor, have invigorating qi for consolidating superficies, inducing diuresis for removing edema, detoxification,
The effect of myogenic, have tonifying Qi, blood-nourishing, benefit in effect, reduce thrombosis, reduce blood pressure, cardioprotection, bidirectional modulation blood glucose,
Green Tea Extract damage, anti-aging, anti anoxia, antitumor, enhancing immunity of organism force effect, can be used to treat heart disease, hypertension,
The diseases such as diabetes;Radix Glycyrrhizae has the function of anti-inflammatory, antiallergic action, effective liquorice glycyrrhizic acid iridium -- glycyrrhizic acid and Radix Glycyrrhizae time
Hydrochlorate, moreover it is possible to inhibit capillary permeability, adrenocortical hormones fuction, Radix Glycyrrhizae that there is salt hydrocortisone sample effect and sugar
Corticosteroid sample acts on, and licoflavone, which also has, to be inhibited tyrosinase activity, removes oxygen mesh by base, and oxidation resistance is given birth to dimension
Plain E is relatively;Inulin contains volatile oil, adenine, choline, stachydrine, chrysanthemum glucoside, amino acid, flavonoids and mcg vitamin
B1, volatile oil is containing borneol, camphor, chrysanthenone etc..Flavonoids has cyanidenon -7- glucose.
6, health care ferment tea solid electuary of the present invention, with ginkgo biloba p.e, black tea powder, honeysuckle powder, astragalus membranaceus powder, Radix Angelicae Sinensis
Based on the Chinese herbal medicines powder such as powder, inulin, longan powder, wolfberry fruit powder, malt flour, licorice powder, longan powder, wolfberry fruit powder, malt flour are
The daily nourishment food of people makes strong ferment increase abundant nutritional ingredient.Apple vinegar with cider it is fermented made of apple it is former
Vinegar, mouthfeel is in acidity, in alkalinity after human body metabolism, there is the function of neutralizing that fish, meat, egg, rice, face etc. are in acid food, and
Be conducive to the preservation of various nutrients and promote the absorption of calcium, contains a kind of particular matter pectin in apple vinegar, intestines can be reduced
Interior undesired bacteria quantity plays enteron aisle toxin expelling effect to help beneficial bacteria to breed.Contain abundant vitamin in fruit vinegar,
Vitamin can inhibit skin pigment to be formed, and eliminate skin splash and increase white element, play beautifying face and moistering lotion, senile-resistant efficacy.Fruit vinegar
In the polysaccharide, potassium ion, the tartaric acid that contain, internal acidity can be reduced together with honey, to relieve fatigue.Include abundant zinc
Element has the function of enhancing memory;18 amino acid and various trace elements needed by human are rich in fruit vinegar:Potassium,
Calcium, zinc, magnesium, sodium, copper etc..Cholesterol is reduced so as to play softening blood vessel;Whet the appetite protect liver, enhancing metabolism, raising human body
Disease resistance.
Specific implementation mode
In order to better understand the present invention, the present invention is further described with reference to specific embodiment.
A kind of health care ferment tea solid electuary of present invention offer and its method, health care ferment tea material liquid are prepared, including following
Raw material:
8~10 parts of ginkgo biloba p.e, 10~12 parts of black tea powder, 5~8 parts of honeysuckle powder, 4~6 parts of astragalus membranaceus powder, angelica powder 5~7
Part, 10~12 parts of inulin, 4~6 parts of longan powder, 5~7 parts of wolfberry fruit powder, 10~12% parts of malt flour, 4~6 parts of licorice powder.
Embodiment 1:
It is prepared by health care ferment tea material liquid:Fermentation tank disinfection and sterilization, raw material by weight, by ginkgo biloba p.e 8kg, black tea powder
10kg, honeysuckle powder 5kg, astragalus membranaceus powder 4kg, angelica powder 5kg, inulin 10kg, longan powder 4kg, wolfberry fruit powder 5kg, malt flour 10kg,
Licorice powder 4kg10 kind raw materials are placed in fermentation tank, add the 3 times of purified water heating stirring dissolvings of raw material total amount;Again plus raw material total amount
With rock sugar 15kg, mixed dissolution, sterilizing 25 minutes.
When temperature is down to 30 DEG C, the saccharomycete activating solution for being added 6% carries out one time fermentation, stirs evenly closed, heat preservation 30
DEG C, when ethanol content reaches 5.5%, stop fermentation;It adds 6% acetic acid bacteria and carries out secondary fermentation, stir evenly closed, heat preservation
30 DEG C, when ethanol content is less than 1%, stop fermentation;It adds 8% probiotics to be fermented three times, stirs evenly closed, heat preservation
35 DEG C, health care ferment tea material liquid is made.
Embodiment 2:
It is prepared by health care ferment tea material liquid:Fermentation tank disinfection and sterilization, by weight ratio, by ginkgo biloba p.e 10kg, black tea powder
12kg, honeysuckle powder 8kg, astragalus membranaceus powder 6kg, angelica powder 7kg, inulin 12kg, longan powder 6kg, wolfberry fruit powder 7kg, malt flour 12kg,
Licorice powder 6kg10 kind raw materials are placed in fermentation tank, add the 3.5 times of purified water heating stirring dissolvings of raw material total amount;Again plus raw material total amount
Match rock sugar 23kg, mixed dissolution, sterilizing 30 minutes.
When temperature is down to 35 DEG C, the saccharomycete activating solution for being added 8% carries out one time fermentation, stirs evenly closed, heat preservation 35
DEG C, when ethanol content reaches 6.5%, stop fermentation;It adds 8% acetic acid bacteria and carries out secondary fermentation, stir evenly closed, heat preservation
35 DEG C, when ethanol content is less than 1%, stop fermentation;It adds 10% probiotics to be fermented three times, stirs evenly closed, guarantor
38 DEG C of temperature, is made health care ferment tea material liquid.
Embodiment 3:
It is prepared by health care ferment tea material liquid:Fermentation tank disinfection and sterilization, by weight ratio, by ginkgo biloba p.e 9kg, black tea powder
11kg, honeysuckle powder 7kg, astragalus membranaceus powder 5kg, angelica powder 6kg, inulin 11kg, longan powder 5kg, wolfberry fruit powder 6kg, malt flour 11kg,
Licorice powder 5kg10 kind raw materials are placed in fermentation tank, add the 3.5 times of purified water heating stirring dissolvings of raw material total amount;Again plus raw material total amount
Match rock sugar 20kg, mixed dissolution, sterilizing 25 minutes.
When temperature is down to 35 DEG C, the saccharomycete activating solution for being added 7% carries out one time fermentation, stirs evenly closed, heat preservation 33
DEG C, when ethanol content reaches 6%, stop fermentation;It adds 7% acetic acid bacteria and carries out secondary fermentation, stir evenly closed, heat preservation 32
DEG C, when ethanol content is less than 1%, stop fermentation;It adds 7% probiotics to be fermented three times, stirs evenly closed, heat preservation 35
DEG C, health care ferment tea material liquid is made.
Health care ferment tea solid electuary produces, and honey, apple vinegar flavor adjustment are added in health care ferment tea material liquid, is filtered with micropore
Membrane filtration, then spraying is freeze-dried into ferment tea powder, finally upper racking machine dresses up disposable health ferment tea solid with aluminium foil bag
Electuary.
The embodiments of the present invention have been described in detail above, but content is only the preferred embodiment of the present invention,
It should not be construed as limiting the scope of the present invention.All changes and improvements made in accordance with the scope of the present invention, should all be still
It belongs within this patent covering scope.
Claims (2)
1. a kind of health care ferment tea solid electuary, it is characterised in that:Including following raw material:
8~10 parts of ginkgo biloba p.e, 10~12 parts of black tea powder, 5~8 parts of honeysuckle powder, 4~6 parts of astragalus membranaceus powder, angelica powder 5~7
Part, 10~12 parts of inulin, 4~6 parts of longan powder, 5~7 parts of wolfberry fruit powder, 10~12% parts of malt flour, 4~6 parts of licorice powder, are equipped with original
Expect 20~30% candy sugar powder of total amount, it is fermented to be processed into health care ferment tea solid electuary;
A kind of production method of health care ferment tea solid electuary, procedure of processing are as follows:
1)Fermentation tank disinfection and sterilization, by ginkgo biloba p.e, black tea powder, honeysuckle powder, astragalus membranaceus powder, angelica powder, inulin, longan
10 kinds of powder, wolfberry fruit powder, malt flour, licorice powder raw materials are placed in fermentation tank according to the ratio, and 3~3.5 times of purified waters of raw material total amount is added to add
Thermal agitation is dissolved;Again plus 20~30% candy sugar powders of raw material total amount, mixed dissolution sterilize 25~30 minutes;
2)When temperature is down to 30~35 DEG C, be added 6~8% saccharomycete activating solution carry out one time fermentation, stir evenly it is closed,
30~35 DEG C of heat preservation stops fermentation when ethanol content reaches 5.5~6.5%;
3)Add 6~8% acetic acid bacterias carry out secondary fermentation, stir evenly it is closed, keep the temperature 30~35 DEG C, wait for that ethanol content is less than
When 1%, stop fermentation;
4)8~10% probiotics are added to be fermented three times, stir evenly it is closed, keep the temperature 35~38 DEG C, ferment tea material is made
Liquid.
2. a kind of production method of health care ferment tea solid electuary according to claim 1, it is characterised in that:The ferment
In feed liquid plus honey, apple vinegar flavor adjustment, with filtering with microporous membrane, then it is freeze-dried spraying into ferment tea powder, finally upper point
Installation dresses up disposable health ferment tea solid electuary with aluminium foil bag.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810157765.4A CN108323600A (en) | 2018-02-24 | 2018-02-24 | A kind of health care ferment tea solid electuary and its production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810157765.4A CN108323600A (en) | 2018-02-24 | 2018-02-24 | A kind of health care ferment tea solid electuary and its production method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108323600A true CN108323600A (en) | 2018-07-27 |
Family
ID=62929499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810157765.4A Pending CN108323600A (en) | 2018-02-24 | 2018-02-24 | A kind of health care ferment tea solid electuary and its production method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108323600A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430476A (en) * | 2018-12-25 | 2019-03-08 | 保山市365生态产业研究所 | Tea ferment drink and preparation method thereof with defaecation ease constipation function |
CN109588600A (en) * | 2019-01-25 | 2019-04-09 | 安徽新天生物科技有限公司 | A kind of Lu`an Guapian.Tea enzyme beverage and preparation method thereof |
CN110537596A (en) * | 2019-08-16 | 2019-12-06 | 大别山野岭饮料股份有限公司 | Enzyme tea and production process thereof |
-
2018
- 2018-02-24 CN CN201810157765.4A patent/CN108323600A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430476A (en) * | 2018-12-25 | 2019-03-08 | 保山市365生态产业研究所 | Tea ferment drink and preparation method thereof with defaecation ease constipation function |
CN109588600A (en) * | 2019-01-25 | 2019-04-09 | 安徽新天生物科技有限公司 | A kind of Lu`an Guapian.Tea enzyme beverage and preparation method thereof |
CN110537596A (en) * | 2019-08-16 | 2019-12-06 | 大别山野岭饮料股份有限公司 | Enzyme tea and production process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9950024B2 (en) | Traditional Chinese medicine composition and the use thereof | |
CN103211256B (en) | Apple vinegar health care beverage for reducing blood fat and preparation method thereof | |
CN101716007A (en) | Cassia bark and ginger health-care beverage and preparation method thereof | |
KR20130029098A (en) | Mathod for manufacturing ion mineral using silk worm, muberry leaf, and muberry twig and health drink manufactured by this | |
KR101202988B1 (en) | Healthy beverage and its manufacturing method | |
CN108323600A (en) | A kind of health care ferment tea solid electuary and its production method | |
CN103238889B (en) | Anti-fatigue apple vinegar health beverage and preparation method thereof | |
CN109497227A (en) | A kind of brown sugar Qi jujube Health care ginger tea | |
CN106387582A (en) | Method of preparing enzymes by fermenting cereals | |
CN105851740A (en) | Health-care beverage capable of invigorating stomach and promoting digestion and making method thereof | |
CN107865100A (en) | A kind of ginseng ginger juice health-care milk beverage and preparation method thereof | |
CN105255637A (en) | Health maintenance liquor and brewing method thereof | |
CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
CN101884408B (en) | Ginkgo leaf leaching liquor and preparation method thereof | |
CN104431125A (en) | Sea-buckthorn honey tea and preparation method thereof | |
CN105176773A (en) | Pumpkin wine capable of adjusting blood glucose and making method thereof | |
KR101606913B1 (en) | Health beverage manufacturing method using turmeric | |
KR101391647B1 (en) | Anti obesity composition | |
CN106721809B (en) | Three high black Conditions of Onion Juice dietary products of a kind of regulation and preparation method thereof | |
CN104473283A (en) | Rose-ginger vinegar beverage and preparation method thereof | |
CN104642607A (en) | Low-sugar gingko tea drink and preparation method thereof | |
CN108552528A (en) | A kind of protection blood vessel and strengthen immunity Kiwi berry ferment and its production method | |
CN109497228A (en) | A kind of brown sugar ginger tea and preparation method thereof | |
CN103222655B (en) | Yellow spot-removing apple vinegar health-care beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180727 |